Hormone Replacement Therapy (HRT) DNA test
At menopause, the sudden drop in estrogen causes many psycho-vegetative disorders such as hot flashes, anxiety or depression, as well as other physiological ones in the longer term: increased cardiovascular risk, osteoporosis, obesity, diabetes, Alzheimer's, among others.
The use of Hormonal Replacement Therapy in menopause (HRT), within the first few years that has been established, involves a reduction in the risk of many diseases, particularly if this treatment has been maintained for more than 10 years.
The Hormone Replacement Treatment (HRT) is recommended to be prescribed by all Menopause, Obstetrics and Gynecology societies of the world.
Benefits of Hormonal Replacement Therapy: Better quality of life. Higher skin quality. Lower risk of dementia. Osteoporosis prevention. Lower risk of colon cancer. Lower risk of obesity and diabetes. Lower risk of Alzheimer's
ESTROgenes is a preventive test that reports the genetic variants related to the metabolism of estrogens, estrogen receptors, progesterone, and genes associated with thrombosis and cardiovascular diseases.
ESTROgenes evaluates this genetic predisposition and therefore allows the estimation of the most appropriate hormonal dose, as well as the evaluation of whether the beneficial effects of hormone therapy exceeds the potential risk of developing these pathologies.
Because certain genetic variants that may have some women, HRT may cause a risk of thrombosis and / or breast cancer. This risk may affect 5-10% of women.
ESTROgenes is indicated before initiating hormone replacement therapy (HRT), to preventively assess the possible individual risk of breast cancer or thrombosis.
ESTROgenes provides personalized recommendations for THR that allow individualized prescription, dosage and duration of treatment.
ESTROgenes also provides nutrigenetic recommendations on the most appropriate diet and lifestyle for each woman, to support the hormone replacement treatment.
